Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Set-Point Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Emergex Vaccines Holding
Deal Size : Undisclosed
Deal Type : Acquisition
Details : Acquisition brings critical technical pre-clinical vaccine development capabilities in-house and establishes US based Emergex subsidiary.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
January 09, 2020
Lead Product(s) : Set-Point Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Emergex Vaccines Holding
Deal Size : Undisclosed
Deal Type : Acquisition